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Abstract
Background: Cardiac catheterization may cause retinal embolization, a risk factor for cerebrovascular emboli and
stroke. We describe the incidence of clinically silent and apparent retinal emboli following diagnostic and
interventional coronary catheterization and associated risk factors.
Methods: Three hundred selected patients attending a tertiary referral center for diagnostic and therapeutic
cardiac catheterization were studied. Retinal examination and examination of the visual field and acuity were done
before and after catheterization by a retinal specialist.
Results: There were 5 case of retinal embolus before catheterization, and 19 patients (incidence 6.3%) developed
new retinal arteriolar emboli after catheterization. Only 1 patient developed clinically apparent changes in vision.
Two conventional risk factors (age and hypertension) were significantly associated with new retinal emboli. The risk
of retinal emboli was also significantly associated with operator expertise.
Conclusions: Retinal embolism was found after coronary catheterization in 6.3% of our patients. This finding
indicates that the retinal, and possibly the cerebral circulation, may be compromised more frequently than is
clinically apparent as a complication of coronary catheterization. Age and hypertension are independent predictors
of retinal embolism.
Trial Registration: NCT01157338
Background
Coronary atherosclerosis is the leading cause of death
and disability in the developed world. Coronary angio-
graphy and angioplasty are currently the standard proce-
dures for the diagnosis and treatment of coronary artery
disease. However, these procedures are invasive and
involve a risk of complications such as vascular and
hemodynamic complications, contrast-related reactions,
arrhythmia and myocardial infarction [1]. Moreover,
because of the many opportunities for air, clots, or solid
particles to enter the systemic circulation, embolism is
one of the most serious complications associated with
coronary catheterization [2]. The origins of systemic
emboli are varied and include atheromatous emboli,
cholesterol emboli (from ulcerated plaques), thrombus
formation at the catheter tip [3,4], air embolism [5,6]
and rarely, foreign materials from the catheter or guide
wire [7].
Cholesterol emboli during catheterization are thought
to be caused by the disruption of a vascular plaque
(mainly by catheter manipulation) with the release of
subendothelial cholesterol crystals into the blood stream
[8]. One of the most dangerous consequences of choles-
terol emboli is central nervous system (CNS) emboli,
which can result in stroke, a rare but serious complica-
tion of cardiac catheterization [1,9]. The risk of clinically
apparent stroke attributable to cardiac catheterization is
reported to be between 0.11% and 0.38% [3]; however, a
high incidence of post-catheterization asymptomatic cer-
ebrovascular embolism (15%) was documented in a
study that compared pre- and post- coronary catheteri-
zation brain magnetic resonance images [10]. Another
study showed a 10-fold increase in the incidence of
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an index retinal embolus over the stroke incidence seen
in a control group over the same period [11]. It was also
shown that persons with retinal emboli at baseline had
an increased risk of dying of stroke compared to those
without retinal emboli. After adjustment for systemic
factors, a fatal stroke was about 3 times as likely in per-
sons with retinal emboli during an 8-year period as in
persons without retinal emboli [12].
The ophthalmic artery is the first major branch of the
internal carotid artery and thus emboli from the heart
and great vessels proximal to the carotid tend to directly
go to the eye. Retinal arteriolar emboli are generally
described as discrete plaque-like lesions in the lumen of
the retinal arterioles or at bifurcations. They are com-
posed of fibrin-platelet aggregates, cholesterol fragments,
or particles of calcified valves. They originate predomi-
nately from an ulcerated atheromatous carotid artery or
ascending aorta plaque, calcified aortic valves, or a
mural internal carotid thrombus, and are classified as
cholesterol (reflective or refractile), fibrin-platelet (dull
or nonreflective) or calcific (chalky white) [13]. Retinal
emboli may be a simply detectable predictor of CNS
embolism. Previous studies have reported rates of retinal
emboli between 55% and 100% after bypass surgery, and
1.25% and 13.2% after carotid stenting [14-16]. The rate
of retinal emboli after cardiac catheterization is still con-
troversial. Peri-coronary catheterization retinal emboli
occur during or immediately after the procedure, when
the femoral artery sheath is still in place [17]. Retinal
cholesterol emboli, known as Hollenhorst plaques, have
a distinctive focal bright, refractive yellow-orange
appearance [18]. Retinal emboli are partially obstructive
and asymptomatic most of the time [9]; however, central
retinal occlusion, although rare, is an emergency situa-
tion whose treatment remains highly uncertain and con-
troversial [2]. Some treatments such as intravenous
mannitol or beta-blockers and oral acetazolamide do
not appear to be fully effective. An experimental study
of central retinal artery occlusion showed that occlusion
lasting about 97 min resulted in massive, irreversible
damage. Thus, no treatment instituted much longer
than 1.5 hours after the onset can be expected to restore
vision [19-21].
We aimed to assess the incidence of acute retinal
embolism after coronary catheterization. In addition, we
sought possible risk factors that may increase the possi-
bility of this complication.
Methods
Study population
From February 2009 to March 2010, 300 patients who
underwent diagnostic (n = 150) or therapeutic coronary
catheterization (n = 150) were included in our study.
There were 156 men and 144 women, and mean age
was 59.36 ± 7.86 years. Exclusion criteria were arrhyth-
mia (especially atrial fibrillation), significant valvular
heart disease confirmed by transthoracic echocardiogra-
phy, and peripheral vascular disease. Patients with
minor coronary artery disease (stenosis less than 50%)
were excluded from the study. Written informed con-
sent was obtained from all patients, and the study was
approved by the research ethic committee of the Shiraz
University of Medical Sciences and Kowsar Hospital.
Study protocol
Complete medical history and findings on physical
examination were documented for each patient, and car-
diovascular risk factors such as dyslipidemia, diabetes
mellitus, smoking, hypertension, and obesity were
recorded. Procedural data (i.e., use of balloon, size of
stent, fluoroscopy time and the total duration of the
procedure excluding fluoroscopy time) were recorded.
The number of occluded vessels and degree of stenosis
were recorded.
Coronary catheterization via a femoral access point
was performed by 5 experienced cardiologists, each with
at least 4 years of experience in cardiac catheterization.
In all patients who underwent diagnostic angiography,
standard coronary angiography was done according to
the Seldinger method, with a 6F catheter and guide
wire. No heparin was given for diagnostic angiography.
For percutaneous transluminal coronary angioplasty
with stent implantation with or without balloon dilation,
a 6F or 7F catheter was used. These patients were given
10 000 international units of heparin as a bolus to main-
tain an activated clotting time of more than 250 s, and
received at least 360 mg aspirin and 600 mg clopidogrel
bisulfate before the angioplasty. A standard nonionic
contrast medium (Omnipaque or Visipaque, GE,
Buckinghamshire, UK or Ultrvist, Bayer HealthCare
Pharmaceuticals, Leverkusen, Germany) was used. For
diagnostic angiography, sheaths were removed immedi-
ately after the procedure. In patients who underwent
therapeutic catheterization, the sheaths were removed 6
h after the procedure.
Eye examination
One day before the procedure, visual acuity was deter-
mined with the Snellen chart and visual field was mea-
sured with the confrontation test and subjective history.
The visual field and visual acuity were checked again
24 h after the procedure. Retinas were examined by a
retinal subspecialist. Pre-catheterization (median 19 h,
range 13-25 h) and post-catheterization examinations
(45 h, 17-96 h) were done by a retinal specialist after
pupil dilation with 1.0% tropicamide. The macula and
posterior pole were examined with a 78D non-contact
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with a Volk 2.2D lens was done to visualize the periph-
eral portions of retina. We did not use digital retinal
photography because this technique cannot visualize the
retina beyond 60 degrees, so small peripheral emboli
would be missed.
Statistical analysis
For statistical analyses, the patients were classified into
two groups: those with and those without retinal emboli.
For categorical and noncategorical variables, we used the
chi-squared test to determine whether differences
between groups were significant. A P value < 0.05 was
considered significant.
Results
Final study population
Of the 408 patients initially recruited, cardiac catheteri-
zation was performed in 406, but only 300 patients
attended their post-catheterization eye examination.
Twenty patients had normal angiograms or mild coron-
ary artery disease, and the others refused further coop-
eration. Therefore, this report is based on statistical
analysis of the data for 300 patients (mean age 59.36 ±
7.86 years, 156 men and 144 women).
Risk factors
Our analysis is based on just 300 patients, so the present
study lacks sufficient power to draw firm conclusions
about differences in risk factors between the two groups.
Most risk factors such as dyslipidemia, male sex, smok-
ing, diabetes mellitus and body mass index did not differ
significantly between patients with and without new ret-
inal emboli (Table 1). Stent length, stent diameter,
fluoroscopy time, total duration of the procedure, and
balloon insertion before the intervention had no effect
on the incidence of new emboli (Table 2). Severity of
coronary artery disease had no effect on the rate of ret-
inal emboli, but age and hypertension were significantly
associated with the appearance of new retinal lesions
(Table 1). We also found a significant correlation
between operator expertise and the risk of new retinal
emboli (Table 2).
Eye examination
Retinal examination by the retinal specialist showed that
5 patients (1.7%) had prior retinal emboli: 3 in the
angiography (diagnostic) group (2%) and 2 in the angio-
plasty (therapeutic) group (1.33%). All of them were
cholesterol emboli. These numbers were too small for
valid statistical comparison. Post-procedure retinal
examination diagnosed a total of 19 new lesions (6.33%).
Of these 19 patients, 8 had undergone cardiac catheteri-
zation for diagnostic purposes (5.33%) and the remain-
ing 11 (7.33%) for therapy.
There was no significant difference between groups in
the location of emboli in the right or left eye (10 lesions
in the right eye and 9 in the left; P > 0.05). Seven of 19
lesions were located in the upper temporal field, 5 in
the lower temporal, 5 in the lower nasal and the remain-
ing 2 in the upper nasal field. All lesions were small and
peripheral and caused only partial obstruction except in
one case, a 72-year-old woman who complained of a
large scotoma in the visual field of her right eye. On
examination she had normal visual field and acuity, but
ophthalmoscopic investigation revealed central emboli
with partial obstruction in the main branch of the ret-
inal artery (Figure 1).
Visual field and acuity were tested within 24 h after
catheterization. The findings of all post-procedure visual
assessments were negative.
Catheterization procedures
Our search for likely procedural risk factors failed to
identify any potential relationship between risk factors
and the appearance of retinal emboli. Although
we observed, in this small series, a slightly higher inci-
dence of retinal emboli in patients who underwent
Table 1 Characteristics of 300 patients in Shiraz, Iran,
with and without new retinal emboli after cardiac
intervention
Characteristics Post-procedure results
Normal
(n = 281)
New lesions
(n = 19)
P
Age 59 ± 7.83 64.5 ± 6.16 0.018
Sex
Male 146 10 0.955
Female 135 9 0.955
Smoking 43 2 0.573
Diabetes mellitus 87 7 0.593
Hypertension 146 15 0.022
Hyperlipidemia 135 10 0.698
Body mass index >30 43 3 0.955
Table 2 Procedural risk factors, severity of coronary
artery disease, and their relation to new retinal emboli
in 300 patients in Shiraz, Iran
Characteristics Post-procedure results
Normal
(n = 281)
New lesion
(n = 19)
P
Stent length 32.23 ± 13.8 32 ± 17.6 0.591
Stent width 2.87 ± 0.34 2.65 ± 0.2 0.504
Balloon insertion before process 73 6 0.897
Duration of fluoroscopy 8.69 ± 3.94 8.26 ± 2.8 0.871
Duration of procedure 16.11 ± 4.7 19.21 ± 4.28 0.188
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this difference was not significant (P = 0.477).
Fluoroscopy time and duration of the procedure
We found no significant difference in fluoroscopy time
between patients with and without new retinal emboli
(P = 0.871).
Discussion
Of the clinical and procedural variables analyzed in our
sample of 300 patients who underwent diagnostic or
therapeutic catheterization, 2 conventional risk factors
(age and hypertension) and operator expertise were
strongly associated with the appearance of new retinal
emboli. Other conventional and procedural risk factors
showed no significant relation with the appearance of
this lesion. At the start of the study, we hypothesized a
strong association between the severity of coronary
artery disease and the risk of retinal embolization. We
reasoned that more severe coronary artery disease
would be related with more atherosclerosis of the aorta,
which in turn would make patients more susceptible to
retinal emboli. As noted by Segal and colleagues, plaque
broken off from the ascending aorta or the aortic arch
can be the main source of systemic emboli including
retinal lesions [3]. It appears likely that the risk of vas-
cular plaque mobilization increases with aging and
hypertension.
Klein et al. [12] found that the prevalence of baseline
retinal emboli was associated with higher pulse pressure,
hypertension, cardiovascular disease, diabetes mellitus
and past and current smoking. The prevalence of base-
line retinal emboli in their patients was 1.3%. Our study
identified some of the same risk factors, including age
and hypertension, as playing a role in post-procedure
retinal emboli. A prospective cohort study by Thyer et
al. [22] found a prevalence of baseline retinal emboli of
5%, but obtained no evidence suggesting that coronary
catheterization contributes to retinal embolism shortly
after the procedure. Funduscopic examination detected
no new retinal emboli in 97 patients who underwent
coronary catheterization. The differences between their
findings and ours may have arisen, in part, because
Thyer and colleagues included patients with a normal
angiogram in their sample of patients who underwent
coronary catheterization, and their sample was too small
to reveal significant differences.
Kreis et al. [23] found a 2% incidence of acute retinal
embolism after coronary catheterization, and indicated
that the retinal and possibly cerebral circulation may be
more severely compromised more frequently than is
clinically apparent. In their study the main method of
retinal examination was digital retinal photography.
New retinal emboli after cardiac catheterization were
seen in 6.3% of our patients. The reason for our higher
figure compared to the incidence found by Kreis and
Figure 1 A new retinal embolus in the main branch of the retinal artery after catheterization.
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not sensitive enough to detect tiny retinal emboli that
cause partial, peripheral arteriolar obstruction.
Busing et al. [10] found that diagnostic and interven-
tional cardiac catheterization increased the risk of silent
cerebral infarction to 15%. Their sample of 48 patients
was not large enough to analyze risk factors, and they
noted that the statistical analysis of their results was
weak, so they could not evaluate potential risk factors in
detail.
Our figures for the incidence of retinal emboli after
coronary catheterization are based on the findings of
retinal examination by a retinal specialist. Nineteen
patients developed retinal emboli, only one of which
was clinically apparent. With regard to the rate of
emboli formation and their clinical significance, cardiac
catheterization can be considered a safe procedure. In
our patients, all lesions were located in non-eloquent
areas of the retina (one was found in the main branch
of the central retinal artery) and were too small to be
clinically apparent. However, when lesions affect more
important areas of the retina, such as the central retinal
artery, they can have severe clinical consequences. Car-
diologists who perform coronary catheterization should
be cognizant of the clinical symptoms and signs of large
retinal emboli (i.e., any visual complaint, especially a
decrease in visual field or acuity), because they can have
a devastating effect on the retina. Because coronary
catheterization may contribute to retinal artery occlu-
sion, prompt consultation with an ophthalmologist
should be considered if symptoms suggestive of visual
disturbance appear during or soon after coronary
catheterization.
The rate of retinal embolization appeared to be
slightly higher after therapeutic cardiac catheterization
than after diagnostic angiography; however, this differ-
ence was not statistically significant. We suspect that
further manipulation of the aortic root might increase
the risk of embolism, and further research will be
needed to test this hypothesis. Retinal emboli occurring
after cardiac catheterization warrant a careful vascular
workup including a search for the emboli in the aortic
arch, the great vessels and the chambers of the heart
itself. Vascular ultrasound, transesophageal echocardio-
graphy and (potentially) computed tomographic angio-
graphy or magnetic resonance angiography can be
extremely useful in this regard. These techniques, unfor-
tunately, were not available at our center when we stu-
died this cohort.
Conclusion
Our findings in a selected cohort of patients suggest
that cardiac catheterization is safe and feasible. Retinal
emboli are generally clinically silent and do not produce
any visual sequelae; however, age and hypertension are
independent predictors of retinal emboli.
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